Trial Profile
A prospective cohort study to evaluate the efficacy of OK-432 in reducing seroma formation after axillary dissection
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 10 Jul 2017
Price :
$35
*
At a glance
- Drugs Picibanil (Primary)
- Indications Advanced breast cancer
- Focus Therapeutic Use
- 10 Jul 2017 New trial record